Growth Metrics

Merck (MRK) Return on Capital Employed (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -969.00
Dec 31, 2025 -308.00
Sep 30, 2025 280.00
Jun 30, 2025 -87.00
Mar 31, 2025 27.00
Dec 31, 2024 716.00
Sep 30, 2024 -157.00
Jun 30, 2024 1,432.00
Mar 31, 2024 300.00
Dec 31, 2023 -709.00
Sep 30, 2023 203.00
Jun 30, 2023 -1,167.00
Mar 31, 2023 30.00
Dec 31, 2022 -48.00
Sep 30, 2022 -259.00
Jun 30, 2022 198.00
Mar 31, 2022 -40.00
Dec 31, 2021 1,109.00
Sep 30, 2021 301.00
Jun 30, 2021 -128.00
Mar 31, 2021 -87.00
Dec 31, 2020 -752.00
Sep 30, 2020 230.00
Jun 30, 2020 68.00
Mar 31, 2020 77.00
Dec 31, 2019 -396.00
Sep 30, 2019 -110.00
Jun 30, 2019 182.00
Mar 31, 2019 318.00
Dec 31, 2018 75.00
Sep 30, 2018 308.00
Jun 30, 2018 -136.00
Mar 31, 2018 -128.00
Dec 31, 2017 429.00
Sep 30, 2017 -396.00
Jun 30, 2017 181.00
Mar 31, 2017 64.00
Dec 31, 2016 -251.00
Sep 30, 2016 92.00
Jun 30, 2016 106.00
Mar 31, 2016 35.00
Dec 31, 2015 -1,344.00
Sep 30, 2015 163.00
Jun 30, 2015 5.00
Mar 31, 2015 -46.00
Dec 31, 2014 1,542.00
Sep 30, 2014 -215.00
Jun 30, 2014 14.00
Mar 31, 2014 16.00
Dec 31, 2013 -67.00
Jun 30, 2012 132.00
Mar 31, 2012 80.00
Dec 31, 2011 281.00
Sep 30, 2011 180.00
Jun 30, 2011 79.00
Mar 31, 2011 -344.00
Dec 31, 2010 -360.00
Sep 30, 2010 -602.00
Jun 30, 2010 -498.00
Mar 31, 2010 -229.00
Dec 31, 2009 -3,463.00